Search details
1.
Randomized trial of exercise on depressive symptomatology and brain derived neurotrophic factor (BDNF) in ovarian cancer survivors: The Women's Activity and Lifestyle Study in Connecticut (WALC).
Gynecol Oncol
; 161(2): 587-594, 2021 05.
Article
in English
| MEDLINE | ID: mdl-33773809
2.
Patient-reported outcome changes at the end of life in recurrent platinum-resistant ovarian cancer: An NRG oncology/GOG study.
Gynecol Oncol
; 163(2): 392-397, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34548162
3.
Sexual harassment in the work place: Its impact on gynecologic oncology and women's health.
Gynecol Oncol
; 149(2): 227-229, 2018 05.
Article
in English
| MEDLINE | ID: mdl-29526475
4.
Quality of life, symptoms and care needs in patients with persistent or recurrent platinum-resistant ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 150(1): 119-126, 2018 07.
Article
in English
| MEDLINE | ID: mdl-29778506
5.
Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer - An NRG oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 144(3): 459-467, 2017 03.
Article
in English
| MEDLINE | ID: mdl-28089376
6.
Body mass index and mortality in endometrial cancer: A systematic review and meta-analysis.
Gynecol Oncol
; 140(1): 184-90, 2016 Jan.
Article
in English
| MEDLINE | ID: mdl-26524722
7.
Principles of ethics and critical communication during the COVID-19 pandemic.
Gynecol Oncol
; 158(3): 526-530, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32622474
8.
Patient reported outcomes measures in gynecologic oncology: A primer for clinical use, part I.
Gynecol Oncol
; 158(1): 194-200, 2020 07.
Article
in English
| MEDLINE | ID: mdl-32580886
9.
Patient reported outcomes measures in gynecologic oncology: A primer for clinical use, Part II.
Gynecol Oncol
; 158(1): 201-207, 2020 07.
Article
in English
| MEDLINE | ID: mdl-32580887
10.
Feasibility of a lifestyle intervention for overweight/obese endometrial and breast cancer survivors using an interactive mobile application.
Gynecol Oncol
; 137(3): 508-15, 2015 Jun.
Article
in English
| MEDLINE | ID: mdl-25681782
11.
Randomized phase II trial of sorafenib alone or in combination with carboplatin/paclitaxel in women with recurrent platinum sensitive epithelial ovarian, peritoneal, or fallopian tube cancer.
Invest New Drugs
; 32(4): 729-38, 2014 Aug.
Article
in English
| MEDLINE | ID: mdl-24619298
12.
Safety culture in the gynecology robotics operating room.
J Minim Invasive Gynecol
; 21(5): 893-900, 2014.
Article
in English
| MEDLINE | ID: mdl-24769449
13.
Health care and social media platforms in hospitals.
Health Commun
; 29(9): 947-52, 2014.
Article
in English
| MEDLINE | ID: mdl-24295109
14.
Nonclinical parameters affecting primary cesarean rates in the United States.
Am J Perinatol
; 31(3): 213-22, 2014 Mar.
Article
in English
| MEDLINE | ID: mdl-23670226
15.
Management of the late effects of treatments for gynecological cancer.
Curr Opin Oncol
; 25(5): 566-70, 2013 Sep.
Article
in English
| MEDLINE | ID: mdl-23942302
16.
The financial performance of labor and delivery units.
Am J Obstet Gynecol
; 209(1): 17-9, 2013 Jul.
Article
in English
| MEDLINE | ID: mdl-23410692
17.
Does enhanced "bundling" criteria improve outcomes? A comparative study of elective inductions.
J Reprod Med
; 58(9-10): 402-10, 2013.
Article
in English
| MEDLINE | ID: mdl-24050029
18.
Robotic-assisted hysterectomy for the management of severe endometriosis: a retrospective review of short-term surgical outcomes.
JSLS
; 17(1): 95-9, 2013.
Article
in English
| MEDLINE | ID: mdl-23743378
19.
The association between quality of life domains and overall survival in ovarian cancer patients during adjuvant chemotherapy: a Gynecologic Oncology Group Study.
Gynecol Oncol
; 124(3): 379-82, 2012 Mar.
Article
in English
| MEDLINE | ID: mdl-22119995
20.
Survivors of uterine cancer empowered by exercise and healthy diet (SUCCEED): a randomized controlled trial.
Gynecol Oncol
; 125(3): 699-704, 2012 Jun.
Article
in English
| MEDLINE | ID: mdl-22465522